NCT03968588View on ClinicalTrials.gov

Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation

PHASE4CompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

July 29, 2014

Primary Completion Date

November 11, 2016

Study Completion Date

June 14, 2017

Conditions

Disorder Related to Renal Transplantation

Interventions

DRUG

Tacrolimus(reduced), Mycophenolate mofetil(standard)

tacrolimus target trough blood level: 3\~8ng/mL MMF dose: 1.5\~2g/d

DRUG

Tacrolimus(standard), Mycophenolate mofetil(reduced)

tacrolimus target trough blood level: 5\~15ng/mL MMF dose: 0.5\~1g/d

Trial Locations (4)

Unknown

Chonbuk National University Hospital, Jeonju

Gangnam Severance Hospital, Seoul

Samsung Medical Center, Seoul

Ajou University Hospital, Suwon

All Listed Sponsors

lead

Ajou University School of Medicine

OTHER

NCT03968588 - Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation | Biotech Hunter | Biotech Hunter